儿童超声心动图造影增强超声应用
本文概述心脏造影增强超声(CEUS)在儿童及成人超声心动图中的临床应用,包括先天性心脏病等适应证。该技术经静脉注射超声造影剂,可改善因声窗限制或胸壁/心脏几何形态改变而困难的经胸超声心动图,并用于评估缺血。2019年美国FDA批准一种超声造影剂用于儿童超声心动图。
要点
- 心脏CEUS可改善儿童声窗受限(如肥胖)或胸壁/心脏几何形态改变(如术后)时的经胸超声心动图。
- 心脏CEUS可用于先天性和获得性心脏病随访中评估缺血。
- 2019年美国FDA批准一种超声造影剂用于儿童超声心动图。
核心结论
- 心脏CEUS在儿童和青少年中已被证明安全有效,适用于包括先天性心脏病在内的多种临床适应证,可改善经胸超声心动图并评估缺血。
研究设计与样本
- 综述,聚焦超声造影剂在儿童及成人超声心动图中的应用,阐述其诊断价值、安全性及未来应用潜力;未报告系统检索范围与纳入文献数量。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
The safety and benefits of cardiac contrast-enhanced ultrasound (CEUS) have been demonstrated in children and adolescents for a variety of clinical indications, including congenital heart disease. Cardiac CEUS is performed with US and the intravenous administration of ultrasound contrast agents (UCAs). It improves transthoracic echocardiography, which can be challenging in children and adults with acoustic window limitations (e.g., from obesity) and alterations in chest wall and cardiac geometry (e.g., from prior surgical procedures). Cardiac CEUS is also used to evaluate ischemia in the follow-up of congenital and acquired heart disease. In 2019, the United States Food and Drug Administration (FDA) approved a UCA for pediatric echocardiography. This article focuses on the clinical applications of UCAs in pediatric and adult echocardiography, outlining its diagnostic value, safety and potential for future applications.
引用
- Kutty S, Biko DM, Goldberg AB, et al. Contrast-enhanced ultrasound in pediatric echocardiography. Pediatr Radiol. 2021. PMID: 34244848. doi:10.1007/s00247-021-05119-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。